Immediate Impact
1 from Science/Nature 59 standout
Citing Papers
Cefepime–Taniborbactam in Complicated Urinary Tract Infection
2024 Standout
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
Works of Angela Wardman being referenced
Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme
2018
Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Angela Wardman | 292 | 390 | 176 | 6 | 444 | |
| Vassiliki Papaioannou | 191 | 361 | 167 | 5 | 403 | |
| Katrina Yates | 330 | 390 | 227 | 8 | 471 | |
| David van Veenhuyzen | 205 | 250 | 126 | 7 | 376 | |
| Mitsuaki Machida | 209 | 271 | 109 | 6 | 405 | |
| Christopher Cortes | 282 | 403 | 120 | 7 | 431 | |
| Michelle Earley | 291 | 419 | 165 | 16 | 510 | |
| Martha Nepka | 275 | 438 | 171 | 5 | 506 | |
| Valentina Galfo | 192 | 321 | 107 | 17 | 402 | |
| Daniel Cloutier | 183 | 235 | 170 | 15 | 497 | |
| Tsukasa Ito-Horiyama | 359 | 445 | 114 | 6 | 508 |
All Works
Loading papers...